Literature DB >> 1644490

Vitamin K supplementation during prophylactic use of cefoperazone in urologic surgery.

S D Rockoff1, M J Blumenfrucht, R J Irwin, R H Eng.   

Abstract

Cefoperazone, an antibiotic commonly used for prophylaxis of infection, has been associated with hypoprothrombinemia and bleeding. To reduce the risk of bleeding, co-administration of vitamin K has been advised. We reassessed the need for vitamin K use in a retrospective analysis of 50 patients undergoing urologic procedures and who had received cefoperazone for three days to prevent infection. Eleven of 50 patients were given vitamin K because of liver or renal disease. Prothrombin time was not elevated in any of the 50 patients analyzed. We conclude that routine use of vitamin K with cefoperazone for perioperative prophylaxis of infection may be unwarranted in patients without identified risk for bleeding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644490     DOI: 10.1007/bf01704604

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Vitamin K-reversible hypoprothrombinemia in rats: comparison of hypoprothrombinemic changes in various strains of rats caused by vitamin K deficiency and antibiotic treatment.

Authors:  M Matsuura; S Satoh; F Kobayashi; K Uchida; T Matsubara
Journal:  J Toxicol Sci       Date:  1989-08       Impact factor: 2.196

2.  Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate.

Authors:  H Z Park; S P Lee; A L Schy
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

Review 3.  Safety of parenteral third-generation cephalosporins.

Authors:  F R Fekety
Journal:  Am J Med       Date:  1990-04-09       Impact factor: 4.965

4.  The spectrum of vitamin K deficiency.

Authors:  J E Ansell; R Kumar; D Deykin
Journal:  JAMA       Date:  1977-07-04       Impact factor: 56.272

Review 5.  Potential for bleeding with the new beta-lactam antibiotics.

Authors:  F R Sattler; M R Weitekamp; J O Ballard
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

6.  Seizure propensity with imipenem.

Authors:  R H Eng; A N Munsif; B G Yangco; S M Smith; H Chmel
Journal:  Arch Intern Med       Date:  1989-08

7.  Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients.

Authors:  J B Alperin
Journal:  JAMA       Date:  1987-10-09       Impact factor: 56.272

8.  Dietary deficiency of phylloquinone and reduced serum levels in febrile neutropenic cancer patients.

Authors:  J Conly; J Suttie; E Reid; J Loftson; K Ramotar; T Louie
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

Review 9.  Impaired hemostasis caused by beta-lactam antibiotics.

Authors:  F R Sattler; M R Weitekamp; A Sayegh; J O Ballard
Journal:  Am J Surg       Date:  1988-05-31       Impact factor: 2.565

10.  Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients.

Authors:  R B Brown; J Klar; S Lemeshow; D Teres; H Pastides; M Sands
Journal:  Arch Intern Med       Date:  1986-11
  10 in total
  3 in total

1.  Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone.

Authors:  Hakan Alagozlu; Mehmet Cindoruk; Selahattin Unal
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Cefoperazone Induced Gastrointestinal Bleeding.

Authors:  Goutham Reddy Katukuri; Raja Naga Mahesh Maddala; Kusugodlu Ramamoorthi; Manjunatha Hande
Journal:  J Clin Diagn Res       Date:  2016-08-01

3.  Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.

Authors:  ZhuYing Cai; Wei Yang; YingYing He; Qingge Chen; ShiQiang Wang; Xuming Luo; Xiongbiao Wang
Journal:  Drug Saf Case Rep       Date:  2016-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.